Michelle Bowie

667 total citations
21 papers, 367 citations indexed

About

Michelle Bowie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michelle Bowie has authored 21 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Immunology. Recurrent topics in Michelle Bowie's work include interferon and immune responses (5 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related Molecular Pathways (3 papers). Michelle Bowie is often cited by papers focused on interferon and immune responses (5 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related Molecular Pathways (3 papers). Michelle Bowie collaborates with scholars based in United States. Michelle Bowie's co-authors include Victoria L. Seewaldt, Tuan Vo‐Dinh, Andrew M. Fales, Bridget M. Crawford, Hsin‐Neng Wang, Gregory R. Bean, Eric C. Dietze, Catherine Ibarra, Robin J. Marjoram and Xuhui Lee and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

In The Last Decade

Michelle Bowie

20 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Bowie United States 12 218 95 74 68 66 21 367
Grigore Rischitor United Kingdom 6 295 1.4× 86 0.9× 33 0.4× 39 0.6× 6 0.1× 8 410
Guixiang Tan China 9 334 1.5× 53 0.6× 63 0.9× 11 0.2× 31 0.5× 9 375
Yaohua Zhang China 8 183 0.8× 58 0.6× 59 0.8× 76 1.1× 8 0.1× 13 333
Chih‐Yung Yang Taiwan 11 215 1.0× 80 0.8× 131 1.8× 56 0.8× 7 0.1× 24 420
Lavona Casson United States 11 581 2.7× 60 0.6× 61 0.8× 44 0.6× 13 0.2× 14 690
Konstantin Krismer United States 7 162 0.7× 44 0.5× 89 1.2× 30 0.4× 6 0.1× 14 302
Hailey E. Brighton United States 9 155 0.7× 54 0.6× 30 0.4× 61 0.9× 5 0.1× 9 321
Hafiz Muhammad Jafar Hussain China 10 192 0.9× 21 0.2× 48 0.6× 8 0.1× 33 0.5× 28 311
Tatiana Gorletta Italy 9 294 1.3× 31 0.3× 85 1.1× 114 1.7× 5 0.1× 12 468
Shicong Zhu China 12 204 0.9× 89 0.9× 68 0.9× 29 0.4× 9 0.1× 25 337

Countries citing papers authored by Michelle Bowie

Since Specialization
Citations

This map shows the geographic impact of Michelle Bowie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Bowie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Bowie more than expected).

Fields of papers citing papers by Michelle Bowie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Bowie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Bowie. The network helps show where Michelle Bowie may publish in the future.

Co-authorship network of co-authors of Michelle Bowie

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Bowie. A scholar is included among the top collaborators of Michelle Bowie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Bowie. Michelle Bowie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Chen, David Moon, Hong Zhang, et al.. (2025). Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress. Clinical Cancer Research. 31(20). 4345–4360.
2.
Brown, Michael C., Justin Low, Michelle Bowie, & David M. Ashley. (2024). Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance. Journal of Clinical Investigation. 134(23). 1 indexed citations
3.
Najem, Hinda, Shashwat Tripathi, Lisa Hurley, et al.. (2024). IMMU-19. PRECLINICAL THERAPEUTIC ACTIVITY AND PET IMAGING OF STING AGONIST 8803 IN GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii156–viii156. 1 indexed citations
4.
Mazgaeen, Lalita, G. S. Howell, Aaron Briley, et al.. (2024). IMMU-37. PRE-TREATMENT INNATE INFLAMMATION ASSOCIATES WITH SURVIVAL AFTER POLIO VIROTHERAPY AND CAN BE MODULATED TO SENSITIZE GLIOMAS TO IN SITU VACCINATION. Neuro-Oncology. 26(Supplement_8). viii160–viii161. 1 indexed citations
5.
Low, Justin, Michael C. Brown, Zachary J. Reitman, et al.. (2024). Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma. Journal of Clinical Investigation. 134(2). 29 indexed citations
6.
7.
Bowie, Michelle, Janell Hostettler, Yiping He, et al.. (2019). IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA. Neuro-Oncology. 21(Supplement_6). vi126–vi126. 1 indexed citations
8.
Glass, Oliver, Michelle Bowie, Julie A. Fuller, et al.. (2017). Differential response to exercise in claudin-low breast cancer. Oncotarget. 8(60). 100989–101004. 22 indexed citations
9.
Crawford, Bridget M., Hsin‐Neng Wang, Andrew M. Fales, et al.. (2017). SERS-based inverse molecular sentinel (iMS) nanoprobes for multiplexed detection of microRNA cancer biomarkers in biological samples. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10080. 1008008–1008008. 5 indexed citations
10.
Nelson, Erik R., Margaret Kennedy, Michelle Bowie, et al.. (2016). Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface. Oncotarget. 7(51). 84030–84042. 18 indexed citations
11.
Wang, Hsin‐Neng, Bridget M. Crawford, Andrew M. Fales, et al.. (2016). Multiplexed Detection of MicroRNA Biomarkers Using SERS-Based Inverse Molecular Sentinel (iMS) Nanoprobes. The Journal of Physical Chemistry C. 120(37). 21047–21055. 95 indexed citations
12.
Bowie, Michelle. (2015). Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer. World Journal of Clinical Oncology. 6(6). 299–299. 30 indexed citations
13.
D’Amato, Nicholas C., Julie H. Ostrander, Michelle Bowie, et al.. (2012). Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System. PLoS ONE. 7(9). e45684–e45684. 14 indexed citations
14.
Bowie, Michelle, et al.. (2008). IRF-1 Promotes Apoptosis in p53-damaged Basal-type Human Mammary Epithelial Cells: A Model for Early Basal-type Mammary Carcinogenesis. Advances in experimental medicine and biology. 617. 367–374. 13 indexed citations
15.
Bowie, Michelle, Jeffrey J. Delrow, Eric C. Dietze, et al.. (2006). Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis in human mammary epithelial cells. Oncogene. 26(14). 2017–2026. 11 indexed citations
16.
Dietze, Eric C., Michelle Bowie, Krzysztof Mrózek, et al.. (2005). CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5. Journal of Cell Science. 118(21). 5005–5022. 13 indexed citations
17.
Bean, Gregory R., Victoria Scott, Xuhui Lee, et al.. (2005). Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration. Cancer Epidemiology Biomarkers & Prevention. 14(4). 790–798. 32 indexed citations
18.
19.
Bowie, Michelle, Eric C. Dietze, Jeffery J. Delrow, et al.. (2004). Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells. Oncogene. 23(54). 8743–8755. 41 indexed citations
20.
Dietze, Eric C., et al.. (2003). CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. Biochemical and Biophysical Research Communications. 302(4). 841–848. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grigore Rischitor Breakdown of academic impact, for papers by Guixiang Tan Breakdown of academic impact, for papers by Yaohua Zhang Breakdown of academic impact, for papers by Chih‐Yung Yang Breakdown of academic impact, for papers by Lavona Casson Breakdown of academic impact, for papers by Konstantin Krismer Breakdown of academic impact, for papers by Hailey E. Brighton Breakdown of academic impact, for papers by Hafiz Muhammad Jafar Hussain Breakdown of academic impact, for papers by Tatiana Gorletta Breakdown of academic impact, for papers by Shicong Zhu
Rankless by CCL
2026